Republic of Korea vs Togo: Previously treated cases tested for RR-/MDR-TB
Republic of Korea
100.0%
in 2024
Togo
100.0%
in 2024
Republic of Korea rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Republic of Korea
- Togo
How they compare
Republic of Korea currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 6 times across 13 shared years of data; in 2011 it was Togo ahead.
Republic of Korea ranks 1st and Togo ranks 1st of 180 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Republic of Korea | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 68.9% | 13.4% | Togo |
| 2020s | 92.0% | 92.2% | 0.2% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Republic of Korea or Togo?
- Republic of Korea, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Republic of Korea and Togo?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Togo?
- 13 years are reported by both, from 2011 to 2024.
- How do Republic of Korea and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Republic of Korea ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.